Molecule Details
InChIKeyDYNHJHQFHQTFTP-UHFFFAOYSA-N
Compound NameCrenolanib
Canonical SMILESCC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)38
Pfam Stratification Cross-Family
Avg pChEMBL7.08
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11832
Drug NameCrenolanib
CAS Number670220-88-9
Groups investigational
ATC Codes nan
DescriptionCrenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.

Categories: Antineoplastic Agents Heterocyclic Compounds, Fused-Ring Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors Tyrosine Kinase Inhibitors
Cross-references: BindingDB: 185149 ChEBI: 145365 CHEMBL2105728 ChemSpider: 8541584 PDB: 6T2 PubChem:10366136 PubChem:347828178 Wikipedia: Crenolanib ZINC: ZINC000003820043
Target Activities (38)
Target Gene Organism Category Pfam pChEMBL Type Source
P36888 FLT3 Homo sapiens Human PF00047 PF07714 9.1 Kd ChEMBL;BindingDB
Q9Y2K2 SIK3 Homo sapiens Human PF00069 PF23312 8.7 Kd ChEMBL
P30085 CMPK1 Homo sapiens Human PF00406 8.5 Kd ChEMBL
Q9NTK5 OLA1 Homo sapiens Human PF01926 PF06071 8.2 Kd ChEMBL
Q9P2R7 SUCLA2 Homo sapiens Human PF08442 PF00549 8.2 Kd ChEMBL
P04629 NTRK1 Homo sapiens Human PF13855 PF16920 PF07714 PF18613 8.1 Kd ChEMBL
P16234 PDGFRA Homo sapiens Human PF07679 PF25305 PF07714 8.0 IC50 ChEMBL
P38117 ETFB Homo sapiens Human PF01012 7.9 Kd ChEMBL
Q9P289 STK26 Homo sapiens Human PF20929 PF00069 7.9 Kd ChEMBL
Q9H0K1 SIK2 Homo sapiens Human PF00069 PF23312 7.8 Kd ChEMBL
Q96L34 MARK4 Homo sapiens Human PF02149 PF00069 PF00627 7.6 Kd ChEMBL
P07741 APRT Homo sapiens Human PF00156 7.5 Kd ChEMBL
P16083 NQO2 Homo sapiens Human PF02525 7.4 Kd ChEMBL
P41250 GARS1 Homo sapiens Human PF03129 PF00587 PF00458 7.4 Kd ChEMBL
Q13163 MAP2K5 Homo sapiens Human PF00564 PF00069 7.4 Kd ChEMBL
Q9Y6E0 STK24 Homo sapiens Human PF20929 PF00069 7.2 Kd ChEMBL
Q9NWZ3 IRAK4 Homo sapiens Human PF07714 7.2 Kd ChEMBL;BindingDB
P09619 PDGFRB Homo sapiens Human PF00047 PF13927 PF25305 PF07714 7.0 Kd ChEMBL
Q9UKE5 TNIK Homo sapiens Human PF00780 PF00069 7.0 Kd ChEMBL
P24941 CDK2 Homo sapiens Human PF00069 6.9 Kd ChEMBL
Q96RR4 CAMKK2 Homo sapiens Human PF00069 6.9 Kd ChEMBL
Q16512 PKN1 Homo sapiens Human PF02185 PF00069 PF00433 6.8 Kd ChEMBL
P27448 MARK3 Homo sapiens Human PF02149 PF00069 PF00627 6.7 Kd ChEMBL
P51617 IRAK1 Homo sapiens Human PF00531 PF00069 6.6 Kd ChEMBL;BindingDB
O95819 MAP4K4 Homo sapiens Human PF00780 PF00069 6.5 Kd ChEMBL
Q7KZI7 MARK2 Homo sapiens Human PF02149 PF00069 PF00627 6.5 Kd ChEMBL
Q00535 CDK5 Homo sapiens Human PF00069 6.5 Kd ChEMBL
Q8IVH8 MAP4K3 Homo sapiens Human PF00780 PF00069 6.4 Kd ChEMBL
Q9Y4K4 MAP4K5 Homo sapiens Human PF00780 PF00069 6.3 Kd ChEMBL
Q13043 STK4 Homo sapiens Human PF11629 PF00069 6.2 Kd ChEMBL
Q13188 STK3 Homo sapiens Human PF11629 PF00069 6.1 Kd ChEMBL
Q13555 CAMK2G Homo sapiens Human PF08332 PF00069 6.1 Kd ChEMBL
O75460 ERN1 Homo sapiens Human PF00069 PF06479 6.1 IC50 BindingDB
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 6.1 Kd ChEMBL
Q13557 CAMK2D Homo sapiens Human PF08332 PF00069 6.1 Kd ChEMBL
O75385 ULK1 Homo sapiens Human PF12063 PF21127 PF00069 6.1 Kd ChEMBL
O96013 PAK4 Homo sapiens Human PF00786 PF00069 6.0 Kd ChEMBL
P50750 CDK9 Homo sapiens Human PF00069 6.0 Kd ChEMBL
DrugBank Target Actions (2)
Target Gene Target Name Action Type
P12931 SRC Proto-oncogene tyrosine-protein kinase Src inhibitor targets
P16234 PDGFRA Platelet-derived growth factor receptor alpha modulator targets